Saxagliptin and metformin in fixed combination for the treatment of type 2 diabetes in adults

about

Saxagliptin and metformin in fixed combination for the treatment of type 2 diabetes in adults

Item

http://www.wikidata.org/entity/Q37082630

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Saxagliptin and metformin in f ...... t of type 2 diabetes in adults

@en

Saxagliptin and metformin in f ...... of type 2 diabetes in adults.

@nl

type

Item

label

Saxagliptin and metformin in f ...... t of type 2 diabetes in adults

@en

Saxagliptin and metformin in f ...... of type 2 diabetes in adults.

@nl

prefLabel

Saxagliptin and metformin in f ...... t of type 2 diabetes in adults

@en

Saxagliptin and metformin in f ...... of type 2 diabetes in adults.

@nl

P1476

Saxagliptin and metformin in f ...... t of type 2 diabetes in adults

@en

P2093

Brian T Terrell

http://www.w3.org/2001/XMLSchema#string

Mary S Klein

http://www.w3.org/2001/XMLSchema#string

Molly G Minze

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes

Mechanism by which metformin reduces glucose production in type 2 diabetes

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Role of AMP-activated protein kinase in mechanism of metformin action

Diagnosis and classification of diabetes mellitus

10-year follow-up of intensive glucose control in type 2 diabetes

Biology of incretins: GLP-1 and GIP

The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone

Patient considerations and clinical utility of a fixed dose combination of saxagliptin/metformin in the treatment of type 2 diabetes

Saxagliptin: A Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus.

P304

15-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4137/CMED.S8510

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23966808

http://www.w3.org/2001/XMLSchema#string

P921

metformin

type-2 diabetes

P932

3738378

http://www.w3.org/2001/XMLSchema#string